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Abstract
Background: This study investigated early and midterm outcomes after valve-sparing aortic root replacement
(VSSR procedure with De Paulis Valsalva graft) for acute aortic dissection or ascending aortic aneurysm in a single
Chinese hospital center.
Methods: Between September 2005 to July 2013, 38 patients (84.2 % male; mean age, 45.5 ± 12.4) underwent VSSR
procedure with De Paulis valsalva graft for acute aortic dissection or ascending aortic aneurysm and were followed
up clinically and echocardiographically.
Results: Among the 38 cases studied, intensive care unit stay duration was 34.5 (interquartile range, 16–34.6) days;
hospital stay duration was 11.7 ± 7.9 days; operation time was 6.8 ± 1.9 h; and cross-clamping time was 154.4 ± 42.0 min.
There was one intraoperative conversion to Bentall procedure; one re-operation for bleeding; one operative death and
one case who developed complications. Mean follow-up was 39.7 ± 21.7 months (range, 12–108 months; cumulative
rate, 1483 patients-months; follow-up rate, 94 %). At 5 and 10 years, overall freedom from valve replacement was 94 %
and 87 %; freedom from aortic regurgitation grade II or higher was 94 % and 91 %; and freedom from reoperation was
94 % and 90 % years, respectively.
Conclusions: The reimplantation type of valve-sparing procedure appears to be facilitated by the use of the De Paulis
valsalva graft with satisfactory perioperative and midterm results.
Keywords: Valve-sparing aortic root replacement, De Paulis graft VSSR procedure
Background
Until the introduction of valve-sparing aortic root re-
placement (VSSR) in 1992 [1], acute aortic dissection or
ascending aortic aneurysm was traditionally treated by
replacing the root with a composite valve graft [2],
which was limited by patient’s postoperative quality of
life and lifelong dependency on anticoagulation. VSSR
has been reported to be associated with favorable long-
term outcomes and mortality [3]. We report here on the
short- and midterm outcomes of 38 patients who under-
went VSSR with De Paulis Valsalva graft for acute aortic
dissection or ascending aortic aneurysm and were
followed up for up to 9 years at our center in China.
Methods
From September 2005 to July 2013, 38 patients (32
males, 84.2 %; mean age, 45.5 ± 12.4; range, 24–69 years)
underwent VSSR procedure at Anzhen Hospital, Beijing.
As summarized in Table 1, mean age of the overall
cohort (n = 38) was 45.5 ± 12.4 years (range, 24–69);
84.2 % were male; mean body mass index (BMI) was
21.78 ± 8.4; 18 (47.4 %) patients were greater than NYHA
class 3; EuroScore II was 13.9 (IQR, 1.83–23.3); 22
(57.9 %) patients had greater than moderate aortic valve
regurgitation; 7 (18.4 %) patients had Marfan syndrome
and LDS; and 16 (42.1 %) had aortic dissection. Following
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guidelines [4], asymptomatic patients with an aortic root
diameter of more than 55 mm due to an aneurysm of
degenerative origin were selected for operation. If the
patient had been diagnosed with Marfan or LDS, VSSR
procedure was indicated when the aortic root diameter
exceeded 45 mm. VSSR was performed in patients with
acute aortic dissection if the aortic root was destroyed
regardless of the root diameter. This study was approved
by the Regional Ethics Committee of our hospital and all
patients signed informed consents.
Surgical technique [5]
All procedures were performed through a median sternot-
omy using cardiopulmonary bypass. Patients undergoing
isolated aortic root replacement received right atrial two-
stage and central aortic cannulation. In most cases, ante-
grade cerebral perfusion was used throughout the period of
hypothermic systemic circulatory arrest. After ascending
aorta was clamped, the aorta was then transected, the aortic
cusps were carefully inspected for prolapse, tears, calcifica-
tion and perforations. After careful assessment of pertinent
parameters to determine VSSR procedure methodology, the
root was circumferentially dissected down to the aortic
annulus nadir and each coronary artery was sutured as a
button, freed and mobilized. A De Paulis valsalva graft
(Gelweave Valsalva graft, Vascutek Ltd, Renfrewshire,
Scotland) was secured to the aortic annulus and passed on
a horizontal plane below the aortic cusps. Three aortic
Table 1 Preoperative characteristics (n = 38)
Variables Values
Age, years (range) 45.5 ± 12.4 (24–69)
Male gender 32 (84.2 %)
Female gender 6 (15.8 %)
Weight, Kg 73.9 ± 12.3
Height, cm 173.7 ± 9.3
BMI 21.78 ± 8.4







Chronic obstructive pulmonary disease 3
Smoking 13
Peripheral vascular disease 3
Preoperative carnine 86.5 ± 24.0
Preoperative atrial fibrillation or flutter 1
EuroScore II 13.9 (IQR, 1.83–23.3)
Preoperative UCG
LVEF 64.0 ± 6.5
Maximum aortic arch diameter, mm 31 ± 5.9
Maximum aortic root diameter, mm 47.5 ± 11.0
Maximum diameter, mm 48.9 ± 11.1
Sinotubular junction diameter, mm 45.0 ± 9.9









Marfan syndrome and LDS 7
Non-connective tissue disease 31




Bicuspid aortic valve 2
Table 2 Perioperative data (n = 38)
Variable
Operation time, hours 6.8 ± 1.9
Cross-clamping time, minutes 154.4 ± 42.0
Bypass time, minutes 203.1 ± 60.1
Ventilation time, hours 35.2 ± 29.8
Intensive care unit stay duration, hours 34.5 (IQR, 16–34.6)
Postoperative hospital stay duration, days 11.7 ± 7.9
Additional procedures
Coronary artery bypass grafting 4
Mitral valve replacement 1
ASD or VSD closure 4






Acute renal failure 3
Postoperative drainage, mL 1201.3 ± 757.7
Death 1
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junction crests were anchored with 4–0 prolene suture
inside the valsalva graft and throughout the graft wall up to
the height mark. The aortic annulus then were sutured
inside the valsalva graft using interrupted 2–0 polypropylene
horizontal mattress sutures, passed though the wall of the
graft and tied on the outside. The graft was re-implanted on
the left ventricular outflow, and the coronary buttons then
were re-implanted on the graft using 6–0 polypropylene.
The distal anastomosis of the graft was continuously sutured
to the aorta with 4–0 prolene (in aortic arch replacement, it
was sutured to the other graft) (Table 2).
Follow-up
Early death was defined as that occurring within 30
days of the operation. Calculation of postoperative
hospital stay duration did not include early death
cases. The median duration of follow-up for survivors
was 39.7 ± 12.7 months (range, 12–108 months). To
obtain follow-up information, clinical staff would first
contact patients via phone. If patient could not be
reached by telephone, letters were sent to the pa-
tient’s address. No patient was lost to follow-up in
the early stage. Follow-up echocardiography was per-
formed and evaluated for all patients. Postoperative
death and repair failure requiring reoperation (severe
aortic regurgitation, endocarditis and graft infection)
after VSSR were defined as adverse events. Intraoperative
conversion to a valve-replacing procedure due to severe
valve regurgitation also was considered an adverse event
(Figs. 1 and 2).
Fig. 1 Kaplan-Meier analysis of a freedom from aortic insufficiency > grade 2; b freedom from reoperation; and c cumulative survival
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Statistical methods
Data are presented as number and percentage for all
discrete variables. Continuous variables are presented as
mean ± standard deviation or median and interquartile
range. Group comparisons were performed using the stu-
dent t test for normally distributed variables, the Mann–
Whitney U test for ordinal variables, and the Fisher exact
test for categorical variables. A p value less than 0.05 was
considered statistically significant. Overall survival and
freedom from adverse events statistics were estimated
with the Kaplan-Meier survival model. Data were analyzed
with a commercially available software (SPSS Statistics 21;
SPSS, IBM, New York, NY).
Results
Perioperative outcome
The VSSR procedure was performed in 37 patients, and
one patient underwent intraoperative conversion to
Bentall procedure. Within 30 days, there was one (2.6%)
death secondary to lung infection coupled with multiple
organ failure; 16 (42.1 %) emergency operations; and one
(2.6 %) patient required re-exploration for bleeding. Add-
itional procedures included CABG in 4 (10.5 %) patients;
and arch and “trunk” procedure in 16 (42.1 %) patients.
Five (13.2 %) patients developed psychiatric symptoms,
and 3 (7.9 %) acute renal failure.
Mean duration of intensive care unit stay was 34.5
(IQR, 16–34.6) hours; and mean hospital stay was 11.7 ±
7.9 days. At discharge, mean operation time was 6.8 ± 1.9
h, and mean cross-clamping time was 154.4 ± 42.0 min.
Aortic regurgitation less than grade I was documented
echocardiographically in all 37 patients (one conversion to
Bentall procedure) after the VSSR procedure, a significant
reduction from the baseline of 20 (p < 0.001, Table 3).
Midterm follow-up
During mean follow-up time of 39.7 + 12.7 months (range,
12–108 months; cumulative rate, 1483 patient-months;
and follow-up rate, 94 %), there was one death (2.7 %)
secondary to lung infection within one year; one patient
(2.7 %) experienced worsening of aortic regurgitation re-
quiring reoperation and underwent aortic valve replace-
ment; and the degree of regurgitation remained constant
in most patients.
At 1 and 5 years, overall freedom from valve replace-
ment was 94 % and 87 %; freedom from aortic regurgita-
tion grade II or higher was 94 % and 91 % (included the
one patient re-operated for aortic insufficiency); and
freedom from reoperation was 94 % and 90 % years, re-
spectively. Freedom from reoperation in patients without
additional cusp repair was 92 % and 87 % at 1 and 5 years,
respectively, which was not significantly different from
those patients who required additional cusp repair (free-
dom from reoperation of 100 % at 5 years, P = 0.211).
Discussion
As an alternative method to Bentall operation for acute
aortic dissection or ascending aortic aneurysm, David
described an approach in which the aortic root wall is
replaced by a straight tubular prosthesis thereby over-
coming the shortcomings of lifelong anticoagulation. Cur-
rently, there are at least 5 modified procedures named









P value 1 P value 2 P value 3
Aortic annulus diameter 25.8 ± 2.7 27.6 ± 1.9 27.8 ± 2.4 28.0 ± 1.9 <0.001 0.884 0.769
Aortic sinus diameter 48.9 ± 11.1 31.8 ± 3.1 30.8 ± 2.7 33.5 ± 3.3 <0.001 0.544 0.875
Aortic regurgitation (moderate to severe) 20 0 1 2 <0.001 0.226 <0.001
LVEF 64.0 ± 6.5 63.4 ± 6.5 63.2 ± 6.1 61.5 ± 6.6 0.634 0.769 0.560
LV end-systolic diameter 34.4 ± 5.6 31.9 ± 4.8 32.4 ± 2.9 31.5 ± 3.6 <0.001 0.812 0.661
LV end-diastolic diameter 53.7 ± 6.1 48.4 ± 5.5 48.7 ± 4.0 49.4 ± 4.9 <0.001 0.793 0.724
Fig. 2 VSSR procedure with De Paulis Valsalva graft
Xu et al. Journal of Cardiothoracic Surgery  (2015) 10:167 Page 4 of 6
David I to V [6] and although evidence on which one is
better is lacking, a growing number of surgeons have been
using David procedures for patients with connective tissue
diseases. However, in the study of Marfan syndrome pa-
tients by Cameron and colleagues [7], the intrinsic leaflet
structure in the graft without sinus structure deteriorated
rapidly, undergoing prolapse and elongation possibly sec-
ondary to loss of tonicity and the free margin impacting
the straight wall of the graft; long-time abrasion would
therefore affect aortic valve leaflets. To address this limita-
tion, in 2000, De Paulis and colleagues [8] introduced a
graft which recreates sinuses and yields relatively favorable
early outcomes: patients who underwent reimplantation
with the Valsalva graft had a significantly smaller annular
diameter, less bleeding, and less residual aortic insuffi-
ciency; however, the authors stressed that a larger patient
cohort and longer follow-up was warranted.
Since 2005, our hospital has been using the VSSR
procedure with De Paulis valsalva graft in patients with
ascending aorta acute dissection or root aneurysm. As
reported in this overview of our experience, one patient
required reoperation for bleeding and there was only
one death, yielding an operative mortality of 2.6 %, and
no significant perioperative morbidity. One patient was
converted to a Bentall procedure intraoperatively. Early
outcomes of the 38 patients demonstrated no dilata-
tion, and no significant aortic insufficiency or progression
thereof.
Several experiences and observations are worth highlight-
ing. First, in our experience, success rate improved
after a learning curve for surgeons’ comprehensive un-
derstanding of anatomy and function of the aortic root
and valve complex. Second, among the 38 patients, 16
who underwent VSSR procedure for acute aortic dissec-
tion, all survived without important events. Relative to the
overall population studied, these patients were younger
(41.8 ± 10.2 years), with a higher EuroScore II (23.4 ± 7.2),
and smaller maximum aortic root diameter (44.7 ± 7.6
mm). The VSSR procedure appears to have been a good
choice for these patients, however, further follow-up data
are warranted.
Third, although VSSR procedure was reserved for cases
with absence of severe aortic regurgitation, and presence
of trileaflet aortic valve and normal cusps, it was per-
formed in 2 cases or bicuspid aortic valve and 7 Marfan
syndrome cases to honor patient’s desire for freedom from
lifelong anticoagulation dependency. Although periopera-
tive outcomes of VSSR were favorable, which could be
related to the young age of the patients (40.7 ± 9.9; range,
24–55), long-term durability of VSSR is unknown in these
cases because mean follow-up was 39.6 months (IQR,
3–71). If the conclusions of this study can be extended
to these patient subsets, the valve and cusp repair
strategies could further change the surgical approach
in bicuspid aortic valve and Marfan syndrome cases
[9–11].
This study has several limitations, including its small
sample size, and limitations in statistical power to com-
paratively analyze subset of patients [12, 13]. Despite
these limitations, this study with up to 9 years of follow-
up documented excellent early and midterm outcomes
in selected patients who underwent aortic root replace-
ment for aneurysms.
Conclusion
This procedure appears to be a safe and appropriate al-
ternative method to mechanical composite valve graft
root replacement in patients who wish to avoid anticoa-
gulation dependency with warfarin.
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